Why the Valeant Pharmaceuticals Stock Price Fell Another 20% This Week

The Valeant Pharmaceuticals stock price crashed another 20% this week amid newly released records that shed some light on the beleaguered drugmaker's operations. The embattled drug giant also said it plans to release delayed Q1 2016 results in June, ahead of the July 31 deadline stipulated in the company's amended credit agreement. Here's why we remain bearish... Tags: Valeant stock To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2016 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Why the Valeant Pharmaceuticals Stock Price Fell Another 20% This Week appeared first on Money Morning - We Make Investing Profitable .